This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Palamarchuk, A. Articles by Pekarsky, Y. Search for Related Content PubMed PubMed Citation Articles by Palamarchuk, A. Articles by Pekarsky, Y.

Akt Phosphorylates Tal1 Oncoprotein and Inhibits Its Repressor Activity

Human Cancer Genetics Program, Comprehensive Cancer Center and Department of Molecular Virology, Immunology, and Medical Genetics, OSU School of Medicine, Ohio State University, Columbus, Ohio

Requests for reprints: Yuri Pekarsky, Comprehensive Cancer Center, Ohio State University, 435 Wiseman Hall, 410 West 12th Avenue, Columbus, OH 43210. Phone: 614-292-3120; Fax: 614-292-3312; E-mail: Pekarsky.Yuri{at}osumc.edu.

The helix-loop-helix transcription factor Tal1 is required for blood cell development and its activation is a frequent event in T-cell acute lymphoblastic leukemia. The Akt (protein kinase B) kinase is a key player in transduction of antiapoptotic and proliferative signals in T cells. Because Tal1 has a putative Akt phosphorylation site at Thr90, we investigated whether Akt regulates Tal1. Our results show that Akt specifically phosphorylates Thr90 of the Tal1 protein within its transactivation domain in vitro and in vivo. Coimmunoprecipitation experiments showed the presence of Tal1 in Akt immune complexes, suggesting that Tal1 and Akt physically interact. We further showed that phosphorylation of Tal1 by Akt causes redistribution of Tal1 within the nucleus. Using luciferase assay, we showed that phosphorylation of Tal1 by Akt decreased repressor activity of Tal1 on EpB42 (P4.2) promoter. Thus, these data indicate that Akt interacts with Tal1 and regulates Tal1 by phosphorylation at Thr90 in a phosphatidylinositol 3-kinase–dependent manner.

This article has been cited by other articles:

				J.-M. Terme, L. Lhermitte, V. Asnafi, and P. Jalinot TGF-{beta} induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation Blood, June 25, 2009; 113(26): 6695 - 6698. [Abstract] [Full Text] [PDF]

				Y. Pekarsky, U. Santanam, A. Cimmino, A. Palamarchuk, A. Efanov, V. Maximov, S. Volinia, H. Alder, C.-G. Liu, L. Rassenti, et al. Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181 Cancer Res., December 15, 2006; 66(24): 11590 - 11593. [Abstract] [Full Text] [PDF]

				A. Palamarchuk, N. Zanesi, R. I. Aqeilan, A. Efanov, V. Maximov, U. Santanam, J. P. Hagan, C. M. Croce, and Y. Pekarsky Tal1 transgenic expression reveals absence of B lymphocytes. Cancer Res., June 15, 2006; 66(12): 6014 - 6017. [Abstract] [Full Text] [PDF]

				A. Palamarchuk, A. Efanov, V. Maximov, R. I. Aqeilan, C. M. Croce, and Y. Pekarsky Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein Cancer Res., December 15, 2005; 65(24): 11282 - 11286. [Abstract] [Full Text] [PDF]